FIELD: chemistry.
SUBSTANCE: disclosed is an isolated thymic stromal lymphopoietin protein (TSLP) or antigenic fragment thereof for inducing immune response, as well as a nucleic acid molecule coding it.
EFFECT: invention can find further use in therapy of atopic diseases.
7 cl, 8 dwg, 2 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| FUSION PROTEIN CONTAINING THYMIC STROMAL LYMPHOPOIETIC PROTEIN, VACCINE CONTAINING EXPRESSION VECTOR FOR EXPRESSION OF PROTEINS AND VACCINE COMPRISING SAID EXPRESSION VECTOR | 2012 |
|
RU2617957C2 |
| ANTIBODIES TO CANINE PD-1 | 2014 |
|
RU2761663C2 |
| MONOCLONAL ANTIBODIES AGAINST INTERLEUKIN-31 | 2012 |
|
RU2588462C2 |
| ANTIBODIES TO CANINE INTERLEUKIN-4 ALPHA RECEPTOR | 2016 |
|
RU2736732C2 |
| CANINE INFLUENZA VIRUS, COMPOSITIONS CONTAINING SAID VIRUS AND APPLICATION THEREOF | 2006 |
|
RU2410427C2 |
| COMPOSITIONS OF RECOMBINANT CDV AND ITS USE | 2011 |
|
RU2567337C2 |
| ANTIBODIES TO DOGS' PD-1 | 2014 |
|
RU2732604C2 |
| RECOVERING VIRUS RELATED TO CANINE PARVOVIRUS-2 FROM RACOON | 2010 |
|
RU2565538C2 |
| CANINE ALPHA INTERLEUKIN-4 RECEPTOR ANTIBODIES | 2020 |
|
RU2840044C1 |
| NGF ANTIBODIES AND RELATED METHODS | 2019 |
|
RU2838175C2 |
